IC
IBIO icon

Ikarian Capital’s iBio IBIO Stock Holding History

Ikarian Capital’s Portfolio IBIO Stock Details IBIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.82M Hold
957,062
– – 0.15% 102
2025
Q4 		$1.85M Buy
957,062
+339,735
+55% +$464K 0.14% 105
2025
Q3 		$511K Buy
617,327
+17,414
+3% +$13.4K 0.05% 137
2025
Q2 		$458K Hold
599,913
– – 0.09% 93
2025
Q1 		$2.41M Hold
599,913
– – 0.3% 65
2024
Q4 		$1.47M Sell
599,913
-87
-0% -$224 0.2% 93
2024
Q3 		$1.33M Hold
600,000
– – 0.19% 86
2024
Q2 		$1.27M Hold
600,000
– – 0.22% 65
2024
Q1 		$2.44M Buy
+600,000
New +$754K 0.27% 81

Other funds holding IBIO

AAA
Affinity Asset Advisors New York $1.94B AUM 374.45% 1-Year Est. Return
FLSM
Frazier Life Sciences Management Palo Alto, California $3.89B AUM 201.1% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
LGM
Logos Global Management San Francisco, California $2B AUM 444.09% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
SCM
Sio Capital Management New York $697M AUM 79.73% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return

Ikarian Capital's IBIO Position: Q1 2026 in Review

Ikarian Capital held its iBio (IBIO) position steady in Q1 2026 at 957,062 shares worth $1.82M. The position accounts for 0.15% of the portfolio, ranked #102.

Ikarian Capital first reported a position in IBIO in Q1 2024 and has held it in 9 quarters since. The position peaked at $2.44M in Q1 2024. 52 funds tracked by Wall St. Rank hold IBIO as of Q1 2026.

  • Ikarian Capital held 957,062 shares of iBio worth $1.82M as of Q1 2026.
  • Ikarian Capital left its iBio share count unchanged in Q1 2026.
  • iBio made up 0.15% of Ikarian Capital's portfolio in Q1 2026, its #102 holding.
  • Ikarian Capital first reported a position in iBio in Q1 2024 and has held it in 9 quarters since.
  • Ikarian Capital's iBio position peaked at $2.44M in Q1 2024.
  • 52 funds tracked by Wall St. Rank held iBio as of Q1 2026.

Based on Ikarian Capital's 13F filing for Q1 2026, filed 15 May 2026.